Tech Company Financing Transactions
SamanTree Medical Funding Round
SamanTree Medical, operating out of Lausanne, received $14 million in funding from Relyens, b2venture and BOM.
Transaction Overview
Company Name
Announced On
7/16/2024
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to further develop and commercialize the Histolog® Scanner, expand its reach in Europe and the United States, and enhance its digital suite.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Avenue de Provence 12
Lausanne, 1007
Switzerland
Lausanne, 1007
Switzerland
Phone
Website
Email Address
Overview
SamanTree Medical is born out of a novel ultra-fast confocal microscopy technology invented at EPFL (Switzerland) in 2010. This innovation has found its application in cancer treatment, where it enables medical professionals to identify and remove cancerous tissue with unique accuracy and speed. By allowing for real-time imaging from biopsy taking to intraoperative decision making, this technology can help to improve patient treatment plans and outcomes, making it a crucial tool in the fight against cancer.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/16/2024: doinstruct venture capital transaction
Next: 7/16/2024: PEXX venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs